TGFB2 and amyotrophic lateral sclerosis: It has been shown that intraperitoneal injection of recombinant human TGF-β2 improves the locomotor performance in ALS mice; however, it did not prevent the degeneration of motor neurons and disease progression (Day et al., 2005).